Dalbavancin is a semisynthetic lipoglycopeptide that was designed to improve upon the natural glycopeptides currently available, vancomycin and teicoplanin. It possesses in vitro activity against a variety of Gram-positive pathogens including MRSA and methicillin-resistant Staphylococcus epidermidis (MRSE).
Dalbavancin impurity is used as precursor for synthesis of dalbavancin and inhibits peptidoglycan synthesis in the cell wall of gram-positive bacteria.
Areas of Interest
Metabolites & Impurities
Bacterial Infections Skin and Subcutaneous Tissue Bacterial Infections